Article
Insights into the Mechanism of Ethionamide Resistance in <em>Mycobacterium tuberculosis</em> through an <em>in silico</em> Structural Evaluation of EthA and Mutants Identified in Clinical Isolates
2020-03-31
Abstract excerpt
Mutation in the ethionamide (ETH) activating enzyme, EthA, is the main factor determining resistance to this drug, used to treat TB patients infected with MDR and XDR Mycobacterium tuberculosis isolates. Many mutations in EthA of ETH resistant (ETH-R) isolates have been described but their roles in resistance remain uncharacterized, partly because structural studies on the enzyme are lacking. Thus, we took a two-t...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- cb5aef71-1823-543f-90f5-6e2e44d015cc
- DOI
- 10.20944/preprints202003.0470.v1
